| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 142, Issue 9 3219-3224, Copyright © 1989 by American Association of Immunologists
ARTICLES |
IE Flesch, G Schwamberger and SH Kaufmann
Department of Medical Microbiology and Immunology, University of Ulm, FRG.
Cryptococcus neoformans is an encapsulated yeast-form fungus which causes pulmonary and meningeal infections preferentially in the immunocompromised host. It is thought that cell-mediated immunity is important for acquired resistance against cryptococcosis with activated macrophages as the final effector cells. However, specific polysaccharides in the capsule of C. neoformans protect the fungus from adherence to phagocytes and from subsequent phagocytosis. We have studied extracellular killing of C. neoformans by IFN-gamma-activated macrophages and their products. Murine bone marrow-derived macrophages stimulated with rIFN-gamma for 24 h were able to effectively suppress the growth of C. neoformans and the effect of IFN-gamma was augmented by LPS. Killing of C. neoformans was also achieved by cell-free supernatants from bone marrow-derived macrophages stimulated with IFN- gamma plus LPS. Our results indicate that killing of C. neoformans by activated macrophages is independent from toxic oxygen radicals and mediated by secreted protein(s) of apparent molecular mass of 15 and 30 kDa. These findings indicate that activated macrophages play a major role in host defense, although the fungus resists phagocytosis and remains in the extracellular milieu.
This article has been cited by other articles:
|
|
 |
|
  U. Muller, W. Stenzel, G. Kohler, C. Werner, T. Polte, G. Hansen, N. Schutze, R. K. Straubinger, M. Blessing, A. N. J. McKenzie, et al. IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans J. Immunol., October 15, 2007; 179(8): 5367 - 5377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zaragoza, M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response Infect. Immun., June 1, 2007; 75(6): 2729 - 2739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Wormley Jr., J. R. Perfect, C. Steele, and G. M. Cox Protection against Cryptococcosis by Using a Murine Gamma Interferon-Producing Cryptococcus neoformans Strain Infect. Immun., March 1, 2007; 75(3): 1453 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Siddiqui, R. J. Shattock, and T. S. Harrison Role of Capsule and Interleukin-6 in Long-Term Immune Control of Cryptococcus neoformans Infection by Specifically Activated Human Peripheral Blood Mononuclear Cells Infect. Immun., September 1, 2006; 74(9): 5302 - 5310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Giles, J. E. Stajich, C. Nichols, Q. D. Gerrald, J. A. Alspaugh, F. Dietrich, and J. R. Perfect The Cryptococcus neoformans Catalase Gene Family and Its Role in Antioxidant Defense. Eukaryot. Cell, September 1, 2006; 5(9): 1447 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Giles, I. Batinic-Haberle, J. R. Perfect, and G. M. Cox Cryptococcus neoformans Mitochondrial Superoxide Dismutase: an Essential Link between Antioxidant Function and High-Temperature Growth Eukaryot. Cell, January 1, 2005; 4(1): 46 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. Humphreys, L. Edwards, G. Walzl, A. J. Rae, G. Dougan, S. Hill, and T. Hussell OX40 Ligation on Activated T Cells Enhances the Control of Cryptococcus neoformans and Reduces Pulmonary Eosinophilia J. Immunol., June 15, 2003; 170(12): 6125 - 6132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichols, S. K. Bauman, F. B. Schafer, and J. W. Murphy Differences in Components at Delayed-Type Hypersensitivity Reaction Sites in Mice Immunized with Either a Protective or a Nonprotective Immunogen of Cryptococcus neoformans Infect. Immun., February 1, 2002; 70(2): 591 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Lutz, K. V. Clemons, and D. A. Stevens Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis J. Antimicrob. Chemother., September 1, 2000; 46(3): 437 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Bauman, K. L. Nichols, and J. W. Murphy Dendritic Cells in the Induction of Protective and Nonprotective Anticryptococcal Cell-Mediated Immune Responses J. Immunol., July 1, 2000; 165(1): 158 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Buchanan and H. A. Doyle Requirement for CD4+ T Lymphocytes in Host Resistance against Cryptococcus neoformans in the Central Nervous System of Immunized Mice Infect. Immun., February 1, 2000; 68(2): 456 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Blackstock, K. L. Buchanan, Adekunle M. , Adesina, and J. W. Murphy Differential Regulation of Immune Responses by Highly and Weakly Virulent Cryptococcus neoformans Isolates Infect. Immun., July 1, 1999; 67(7): 3601 - 3609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Murphy, F. Schafer, A. Casadevall, and A. Adesina Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components against Cryptococcus neoformans Infect. Immun., June 1, 1998; 66(6): 2632 - 2639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lipovsky, A. E. Juliana, G. Gekker, S. Hu, A. I. M. Hoepelman, and P. K. Peterson Clin. Vaccine Immunol., May 1, 1998; 5(3): 410 - 411. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
